ReviewGenes & diseases2024

Twenty years of Gendicine® rAd-p53 cancer gene therapy: The first-in-class human cancer gene therapy in the era of personalized oncology.

Li Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.